Testing of aerosolized ciprofloxacin nanocarriers on cystic fibrosis airway cells infected with P. aeruginosa biofilms

A Custom-Made Device for Reproducibly Depositing Pre-metered Doses of Nebulized Drugs on Pulmonary Cells in vitro

(2021) Justus C. Horstmann et al.   Frontiers in Bioengineering and Biotechnology

Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm Infections

(2020) Duy‐Khiet Ho et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Inhaled Liposomal Antimicrobial Delivery in Lung Infections

(2020) Matteo Bassetti et al.   DRUGS

OUP accepted manuscript

(2018)   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis

(2018) Stamatia Chorepsima et al.   Drug Design Development and Therapy

Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections

(2017) Nazende Günday Türeli et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Modelling the bronchial barrier in pulmonary drug delivery: A human bronchial epithelial cell line supplemented with human tracheal mucus

(2017) Xabi Murgia et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach

(2016) Nazende Günday Türeli et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Counter-ion complexes for enhanced drug loading in nanocarriers: Proof-of-concept and beyond

(2016) Nazende Günday Türeli et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

A murine model of early Pseudomonas aeruginosa lung disease with transition to chronic infection

(2016) H. K. Bayes et al.   Scientific Reports

Overcoming barriers in Pseudomonas aeruginosa lung infections: Engineered nanoparticles for local delivery of a cationic antimicrobial peptide

(2015) Ivana d’Angelo et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Nanocomplexes for gene therapy of respiratory diseases: Targeting and overcoming the mucus barrier

(2015) Sante Di Gioia et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Nano-antibiotics in chronic lung infection therapy against Pseudomonas aeruginosa

(2014) Kunn Hadinoto et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Nitrite modulates bacterial antibiotic susceptibility and biofilm formation in association with airway epithelial cells

(2014) Anna C. Zemke et al.   FREE RADICAL BIOLOGY AND MEDICINE

Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells

(2014) S. Moreau-Marquis et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Lipid and polymer nanoparticles for drug delivery to bacterial biofilms

(2014) Katrien Forier et al.   JOURNAL OF CONTROLLED RELEASE

Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis Airways Influences Virulence of Staphylococcus aureus In Vitro and Murine Models of Co-Infection

(2014) Rossella Baldan et al.   PLoS One

The role of bacterial biofilms in chronic infections

(2013) Thomas Bjarnsholt   APMIS

The in vivo biofilm

(2013) Thomas Bjarnsholt et al.   TRENDS IN MICROBIOLOGY

Bacterial Biofilms: Development, Dispersal, and Therapeutic Strategies in the Dawn of the Postantibiotic Era

(2013) M. Kostakioti et al.   Cold Spring Harbor Perspectives in Medicine

Mucin Biopolymers Prevent Bacterial Aggregation by Retaining Cells in the Free-Swimming State

(2012) Marina Caldara et al.   CURRENT BIOLOGY

Mechanical robustness of Pseudomonasaeruginosa biofilms

(2011) Oliver Lieleg et al.   Soft Matter

Antibiotic resistance of bacterial biofilms

(2010) Niels Høiby et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Co-culture Models of Pseudomonas aeruginosa Biofilms Grown on Live Human Airway Cells

(2010) Sophie Moreau-Marquis et al.   Jove-Journal of Visualized Experiments

Tobramycin and FDA-Approved Iron Chelators EliminatePseudomonas aeruginosaBiofilms on Cystic Fibrosis Cells

(2009) Sophie Moreau-Marquis et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus

(2009) Harry Heijerman et al.   Journal of Cystic Fibrosis

Pseudomonas aeruginosabiofilms in the respiratory tract of cystic fibrosis patients

(2009) Thomas Bjarnsholt et al.   PEDIATRIC PULMONOLOGY

In Vitro Analysis of Tobramycin-Treated Pseudomonas aeruginosa Biofilms on Cystic Fibrosis-Derived Airway Epithelial Cells

(2008) G. G. Anderson et al.   INFECTION AND IMMUNITY

Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates

(2007) Elke Peeters et al.   JOURNAL OF MICROBIOLOGICAL METHODS